10바이알 팩재고 282% 할인BPC-157 5 mg
조직 복구 연구 펩타이드
Buy BPC-157 in Australia for research applications. Lab-tested, ≥99% purity, Australian-shipped.
연구 전용. 이 화합물은 체외 연구 및 실험실 용도로만 판매되며, 인체 섭취나 치료 목적 사용을 의도하지 않습니다. 구매함으로써 귀하가 자격을 갖춘 연구자이며 당사의 전체 면책 조항에 동의하는 것으로 간주됩니다.
2팩만 남음
Body Protective Compound 157은 합성 펩타이드 단편입니다. 조직 복구 경로, 혈관신생 기전, 장 점막 온전성에 대한 영향이 연구 모델에서 검토되었습니다.
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide derived from a protective protein originally identified in human gastric juice. It is one of the most extensively studied research peptides in tissue-repair literature, with published work spanning tendon, ligament, gastrointestinal, and vascular models. Quantum Labs supplies BPC-157 as a lyophilised powder in sealed 5 mg vials for research applications.
Australian researchers source BPC-157 through three channels: compounded prescription supply via registered pharmacies, imported reference standards, and research-grade peptide suppliers. Our material falls in the third category — supplied without therapeutic representation, certified to ≥99% HPLC purity, and shipped domestically from Australian stock. Every batch ships with identity confirmation by mass spectrometry available on request.
BPC-157 is most commonly the subject of research stacked with TB-500 (thymosin β-4 fragment), where the combination is studied for synergistic effects on tissue remodelling pathways. We supply both compounds individually and as a pre-portioned BPC-157 + TB-500 research stack.
작용 기전
연구는 BPC-157이 산화질소 경로 및 성장인자 신호와 상호작용하며, 연구 대상의 조직 복구 지표와 관련됨을 시사합니다.
순도 규격 ≥99%에 대해 HPLC로 검증되었습니다. 인증된 제3자 실험실에서 독립적으로 시험합니다.
Research applications
Peer-reviewed work on BPC-157 spans models of tendon and ligament healing, gut-barrier function, inflammatory bowel models, and vascular regeneration. Pentadecapeptide BPC-157 has shown protective effects across multiple organ systems in pre-clinical rodent studies, with proposed mechanisms involving the nitric oxide pathway, VEGF expression, and growth-hormone receptor modulation.
The compound is structurally distinct from native gastric BPC and is stable in human gastric juice — a property that has driven research interest in oral as well as injected delivery formats.
Storage and handling
Lyophilised BPC-157 is stable at room temperature for several weeks and at 2-8°C for several months in unopened sealed vials. Once reconstituted with bacteriostatic water, the working solution is typically stored at 2-8°C and used within 30 days. Avoid freeze-thaw cycles, which can degrade peptide integrity.
Bacteriostatic water for reconstitution is available as a separate research supply — see our Bacteriostatic Water listing.
BPC-157 — 자주 묻는 질문
Is BPC-157 legal in Australia?
BPC-157 occupies a regulatory grey zone in Australia. The Therapeutic Goods Administration (TGA) has restricted compounded BPC-157 for human therapeutic supply, but the compound remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies BPC-157 for research use only — not for human consumption.
What is BPC-157 used for in research?
Published research on BPC-157 spans tissue repair, tendon and ligament healing models, gastrointestinal protection studies, inflammatory bowel models, and vascular regeneration. It is one of the most well-cited tissue-repair peptides in pre-clinical literature. Quantum Labs supplies this compound for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing, treatment effects, or personal use should be directed to a qualified medical practitioner.
What is the typical BPC-157 research dosage?
Published rodent studies have used wide dose ranges from approximately 10 μg/kg to 250 μg/kg, with the most common doses in tendon-healing models falling around 10-20 μg/kg. Human dosing is not established, as BPC-157 is not an approved therapeutic. Researchers should consult primary literature for protocol-specific guidance.
What are the documented side effects of BPC-157?
BPC-157 has shown a wide tolerability margin in pre-clinical rodent studies, with no significant toxicity reported even at doses far above the therapeutic range under study. Long-term human safety data is not available — BPC-157 has not undergone human regulatory trials. Quantum Labs supplies this compound for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing, treatment effects, or personal use should be directed to a qualified medical practitioner.
Can BPC-157 be taken orally?
Research interest in oral BPC-157 stems from the parent molecule's natural origin in gastric juice — making it unusually stable in the gastrointestinal tract for a peptide. Both injected and oral delivery have been used in pre-clinical study designs. Quantum Labs supplies the lyophilised powder; researchers determine the appropriate delivery format for their study.
What's the difference between BPC-157 and TB-500?
BPC-157 is a 15-amino-acid synthetic peptide derived from a gastric protective protein, while TB-500 is a 17-amino-acid fragment of the natural protein thymosin β-4. Both are studied in tissue-repair research and are often used together. BPC-157 research focuses on vascular regeneration and nitric oxide pathway modulation; TB-500 research focuses on actin binding and cell migration.
Where can I buy BPC-157 in Australia?
Quantum Labs ships BPC-157 from Australian stock to verified researchers. Material is HPLC-verified ≥99% purity, third-party tested, and supplied for research use only. Domestic delivery is typically 2-5 business days from payment confirmation.
BPC-157 관련 가이드
연구자들이 함께 살펴보는 항목
추천10바이알 팩22% 할인CJC-1295 + Ipamorelin
동결건조 분말5 mg + 5 mg
고전적 GHRH + 그렐린 모방 스택
2개 스택에 포함
추천10바이알 팩20% 할인TB-500
동결건조 분말5 mg · 2 strengths
액틴 결합 연구 펩타이드